Two Sigma Securities’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,469
Closed -$42K 2610
2021
Q4
$42K Buy
+1,469
New +$57.5K ﹤0.01% 1302
2019
Q2
Sell
-1,283
Closed -$68K 2497
2019
Q1
$68K Buy
+1,283
New +$64K ﹤0.01% 1598

Other funds holding ORGS

Two Sigma Securities's ORGS Position: Q1 2022 in Review

Two Sigma Securities sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2022, closing a stake of 1,469 shares — an estimated $42K sold.

Two Sigma Securities first reported a position in ORGS in Q1 2019 and held it in 2 quarters. The position peaked at $68K in Q1 2019. 22 funds tracked by Wall St. Rank hold ORGS as of Q1 2022.

  • Two Sigma Securities reported no remaining Orgenesis Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,469 Orgenesis Inc. Common Stock shares in Q1 2022, an estimated $42K.
  • Two Sigma Securities first reported a position in Orgenesis Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Two Sigma Securities's Orgenesis Inc. Common Stock position peaked at $68K in Q1 2019.
  • 22 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2022.

Based on Two Sigma Securities's 13F filing for Q1 2022, filed 16 May 2022.